Global Serum Market Revenue and Share Analysis Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the serum market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Serum Market In The Period 2029-2034?

The antivirals market has experienced robust expansion over recent years. This market is projected to expand from $106.64 billion in 2024 to $114.4 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 7.3%. Factors contributing to its historical growth include viral disease prevalence, rising public health concerns, patent expirations, and various government initiatives.

The antivirals market is projected to experience robust expansion over the coming years, with its size forecast to reach $151.54 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this anticipated growth include the emergence of new viral threats and widespread global health initiatives. Key trends shaping the market during this period encompass technological advancements, the rise of telemedicine and digital health solutions, and the increasing adoption of personalized medicine.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

What Strategic Drivers Are Accelerating The Serum Market Expansion?

The rising occurrence of influenza is projected to boost the expansion of the antiviral market moving forward. Influenza, known also as the flu, is a very contagious viral respiratory infection caused by influenza viruses that impact the nose, throat, and lungs. Antivirals serve in the treatment of influenza, designed to stop the replication and spread of these viruses within the body. For example, in October 2022, the Centers for Disease Control and Prevention, a US-based health agency, reported that during the 2021-2022 season, there were 9 million flu illnesses, 4 million flu-related medical visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths. Thus, the increasing incidence of influenza is a primary force behind the growth of the antiviral market.

What Is The Detailed Segment Distribution Of The Serum Market?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

How Are Global Trends Impacting The Development Of The Serum Market?

Leading companies in the antiviral market are focusing on developing innovative treatments, such as oral antiviral medications, to improve patient adherence, increase accessibility, reduce healthcare costs, and provide more convenient and effective options for managing viral infections. Oral antiviral treatment refers to medicines taken orally to treat viral infections. These treatments function by inhibiting viruses from replicating or spreading within the body, which helps to lessen the infection’s severity and duration. For instance, in May 2023, Pfizer, a US-based company providing pharmaceuticals, announced the approval of Paxlovid by the Food and Drug Administration, a US-based government agency, designating it as the first oral antiviral treatment for COVID-19 in adults. This approval is particularly significant as it offers a new therapeutic choice for managing COVID-19, especially as the pandemic transitions towards an endemic phase. Paxlovid is specifically indicated for adults with mild-to-moderate COVID-19 who are at high risk for progression to severe disease, including hospitalization or death.

Who Are The Major Stakeholders Operating In The Serum Market?

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Serum Market?

North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Browse Through More Reports Similar to the Global Serum Market 2025, By The Business Research Company

Anti Infective Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Hospital Acquired Infections Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Anti Viral Drug Therapy Market 2025

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795